A nutraceutical combination of spirulina, reishi and moringa exerts significant cytoprotective effects againts doxorubicin and trastuzumab cardiotoxicity.
Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Raffaele De Anseris(Institute of Food Science), Carlo Maurea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gabriele Conforti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Simona Buccolo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Vincenzo Quagliariello(Cancer Institute (WIA)), Antonietta Caronna(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Carmine Ostacolo(University of Naples Federico II)
Cited by 1
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105
Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction
|European Journal of Heart Failure|2014|92